| ARYx Therapeutics Nets $2 Million Venture Capital Debt |
|
|
| Tuesday, August 31, 2010 5:57:00 AM PDT | VentureDeal Staff |
Fremont, California -- Pharmaceutical company ARYx Therapeutics has received a little over $2 million in venture capital debt, according to a regulatory filing.
ARYx Therapeutics says that it is developing "intellectual property in the area of retrometabolic drug design."
Investors in the financing were not disclosed, nor was how the company intends to use the financing proceeds. |
|
|
 Email Page |  Print Page |
|
|
|
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
|
 |
|
|
|
 |